Is Back on Investors’ Radar Pfizer (PFE) is attracting fresh attention after a period of mixed share performance, with the ...

Shionogi has agreed to raise its stake in London-based drugmaker ViiV Healthcare by acquiring additional shares for $2.125 ...

Invesco Equity And Income Fund's Q4 2025 report highlights strategic shifts toward AI-driven electronics and medical diagnostics. Read the full analysis now.

Invesco Equity and Income Fund lagged its benchmark in Q4 2025 as IT and fixed income weighed. See new holdings and full ...

Rep. Julia Letlow (R-La.) reportedly violated a federal transparency law by failing to disclose her personal stock trades ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 7 includes Pfizer, Philip Morris International, ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...

Any believers in UPS who buy now can enjoy a generous dividend payment every quarter while waiting for a turnaround. Given ...

The lender earned $4.88 per share, easily beating Wall Street's estimate of $4.20. Revenue of $6.07 billion came in higher ...

Pfizer has outperformed the S&P 500 since my previous call, driven by improving fundamentals and renewed share price momentum ...

The U.K. medicines regulator stated that the maximum dose of 7.2 mg of Wegovy only applies to adult patients with a Body Mass ...

Dow, S&P 500, and Nasdaq futures are rising in premarket trading as the stock market reacts to renewed AI hope and easing fears about Trump initiating military action in Iran.